Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,270 | -1,071 | -4,320 | -3,480 | -2,553 |
| Depreciation Amortization | 19 | 10 | 43 | 34 | 24 |
| Accounts payable and accrued liabilities | 322 | 312 | -195 | -141 | -34 |
| Other Working Capital | 435 | 255 | -107 | -205 | -272 |
| Other Operating Activity | -246 | -270 | 501 | 384 | 202 |
| Operating Cash Flow | $-1,740 | $-764 | $-4,078 | $-3,408 | $-2,633 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -9 | N/A | -1 | -1 |
| Investing Cash Flow | $-17 | $-9 | $N/A | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,741 | 1,741 | 1,528 | 681 | N/A |
| Other Financing Activity | 17,470 | -351 | -473 | -134 | -127 |
| Financing Cash Flow | $19,211 | $1,390 | $1,055 | $547 | $-127 |
| Beginning Cash Position | 2,920 | 2,920 | 5,943 | 5,943 | 5,943 |
| End Cash Position | 20,374 | 3,537 | 2,920 | 3,081 | 3,182 |
| Net Cash Flow | $17,454 | $617 | $-3,023 | $-2,862 | $-2,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,740 | -764 | -4,078 | -3,408 | -2,633 |
| Capital Expenditure | -17 | -9 | N/A | -1 | -1 |
| Free Cash Flow | -1,757 | -773 | -4,078 | -3,409 | -2,634 |